new_0222_0040|MRVI|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|sga_expense|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|short_interest|forward_pe_ratio|forward_pe_ratio_1y|forward_ps_ratio|forward_ps_ratio_1y|quarterly_eps_estimates|quarterly_sales_estimates|quarterly_eps_surprise|quarterly_sales_surprise|quarterly_eps_actual|quarterly_sales_actual|sales_est_0y|sales_est_1y|price_target|consensus_recommendation|price_target_num_est|eps_est_0y|eps_est_1y|r_and_d_expense|reconciled_depreciation|interest_expense_non_operating|land_and_improvements|buildings_and_improvements|other_properties|machinery_furniture_equipment|price_next_month|price_second_month
new_0222_0040|MRVI|1|Maravai LifeSciences Holdings Inc Total Current Assets (Quarterly) (USD)|Maravai LifeSciences Holdings Inc Cash and Short Term Investments (Quarterly) (USD)|Maravai LifeSciences Holdings Inc Inventories (Quarterly) (USD)|Maravai LifeSciences Holdings Inc Net PP&E (Quarterly) (USD)|Maravai LifeSciences Holdings Inc Goodwill and Intangibles (Quarterly) (USD)|Maravai LifeSciences Holdings Inc Total Liabilities (Quarterly) (USD)|Maravai LifeSciences Holdings Inc Total Current Liabilities (Quarterly) (USD)|Maravai LifeSciences Holdings Inc Total Long Term Liabilities (Quarterly) (USD)|Maravai LifeSciences Holdings Inc Total Deposits (Quarterly) (USD)|Maravai LifeSciences Holdings Inc Book Value (Quarterly) (USD)|Maravai LifeSciences Holdings Inc Retained Earnings (Quarterly) (USD)|Maravai LifeSciences Holdings Inc Treasury Stock (Quarterly) (USD)|Maravai LifeSciences Holdings Inc EV to Revenues|Maravai LifeSciences Holdings Inc EV to Earnings|Maravai LifeSciences Holdings Inc EV to Free Cash Flow|Maravai LifeSciences Holdings Inc EV to Assets (Quarterly)|Maravai LifeSciences Holdings Inc PS Ratio|Maravai LifeSciences Holdings Inc PE Ratio|Maravai LifeSciences Holdings Inc Price to Book Value|Maravai LifeSciences Holdings Inc PEG Ratio|Maravai LifeSciences Holdings Inc Debt to Equity Ratio|Maravai LifeSciences Holdings Inc Dividend Yield|Maravai LifeSciences Holdings Inc Shareholder Yield (TTM)|Maravai LifeSciences Holdings Inc Percent of Shares Outstanding Short|Maravai LifeSciences Holdings Inc Total Receivables (Quarterly) (USD)|Maravai LifeSciences Holdings Inc Total Payables (Quarterly) (USD)|Maravai LifeSciences Holdings Inc Total Capital Stock (Quarterly) (USD)|Maravai LifeSciences Holdings Inc Return on Invested Capital|Maravai LifeSciences Holdings Inc Quality Ratio Score|Maravai LifeSciences Holdings Inc Momentum Score|Maravai LifeSciences Holdings Inc Beta (1Y)|Maravai LifeSciences Holdings Inc Sustainable Growth Rate (TTM)|Maravai LifeSciences Holdings Inc Institutional Investor Ownership Percentage|Maravai LifeSciences Holdings Inc Average Diluted Shares Outstanding (Quarterly)|Maravai LifeSciences Holdings Inc Total Employees (Annual)|Maravai LifeSciences Holdings Inc EPS Diluted (Quarterly) (USD)|Maravai LifeSciences Holdings Inc SG&A Expense (Quarterly) (USD)|Maravai LifeSciences Holdings Inc Shares Outstanding|Maravai LifeSciences Holdings Inc Repurchase of Capital Stock (Quarterly) (USD)|Maravai LifeSciences Holdings Inc Ordinary Shares Number (Quarterly)|Maravai LifeSciences Holdings Inc Payout Ratio|Maravai LifeSciences Holdings Inc Quick Ratio (Quarterly)|Maravai LifeSciences Holdings Inc Normalized Diluted EPS (Quarterly) (USD)|Maravai LifeSciences Holdings Inc Stock Buybacks (Quarterly) (USD)|Maravai LifeSciences Holdings Inc Effective Tax Rate (TTM)|Maravai LifeSciences Holdings Inc Return on Equity|Maravai LifeSciences Holdings Inc Net Income (TTM) (USD)|Maravai LifeSciences Holdings Inc Revenue (TTM) (USD)|Maravai LifeSciences Holdings Inc Dividend Per Share (Quarterly) (USD)|Maravai LifeSciences Holdings Inc Revenue (Quarterly) (USD)|Maravai LifeSciences Holdings Inc Gross Profit (Quarterly) (USD)|Maravai LifeSciences Holdings Inc Pre-Tax Income (Quarterly) (USD)|Maravai LifeSciences Holdings Inc Net Income (Quarterly) (USD)|Maravai LifeSciences Holdings Inc Net Interest Income (Quarterly) (USD)|Maravai LifeSciences Holdings Inc Price (USD)|Maravai LifeSciences Holdings Inc Total Return Price (USD)|Maravai LifeSciences Holdings Inc Enterprise Value (USD)|Maravai LifeSciences Holdings Inc 30-Day Average Daily Volume|Maravai LifeSciences Holdings Inc 1 Year Price Returns (Daily)|Maravai LifeSciences Holdings Inc Short Interest|Maravai LifeSciences Holdings Inc PE Ratio (Forward)|Maravai LifeSciences Holdings Inc PE Ratio (Forward 1y)|Maravai LifeSciences Holdings Inc PS Ratio (Forward)|Maravai LifeSciences Holdings Inc PS Ratio (Forward 1y)|Maravai LifeSciences Holdings Inc Quarterly EPS Estimates (USD)|Maravai LifeSciences Holdings Inc Quarterly Revenue Estimates (USD)|Maravai LifeSciences Holdings Inc Quarterly EPS Surprise|Maravai LifeSciences Holdings Inc Quarterly Revenue Surprise|Maravai LifeSciences Holdings Inc Quarterly Actual EPS (USD)|Maravai LifeSciences Holdings Inc Quarterly Actual Revenue (USD)|Maravai LifeSciences Holdings Inc Revenue Estimates for Current Fiscal Year (USD)|Maravai LifeSciences Holdings Inc Revenue Estimates for Next Fiscal Year (USD)|Maravai LifeSciences Holdings Inc Price Target (USD)|Maravai LifeSciences Holdings Inc Consensus Recommendation|Maravai LifeSciences Holdings Inc Price Target Num Estimates|Maravai LifeSciences Holdings Inc EPS Estimates for Current Fiscal Year (USD)|Maravai LifeSciences Holdings Inc EPS Estimates for Next Fiscal Year (USD)|Maravai LifeSciences Holdings Inc Research and Development Expense (Quarterly) (USD)|Maravai LifeSciences Holdings Inc Reconciled Depreciation (Quarterly) (USD)|Maravai LifeSciences Holdings Inc Non-Operating Interest Expense (Quarterly) (USD)|Maravai LifeSciences Holdings Inc Land and Improvements (Quarterly) (USD)|Maravai LifeSciences Holdings Inc Buildings and Improvements (Quarterly) (USD)|Maravai LifeSciences Holdings Inc Other Properties (Quarterly) (USD)|Maravai LifeSciences Holdings Inc Machine, Furniture & Equipment (Quarterly) (USD)||
new_0222_0040|MRVI|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_per_share_metric|percent_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_USD_metric|figure_whole_USD_price|figure_money_USD_per_share_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric||
new_0222_0040|MRVI|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|monthly|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|monthly|monthly|monthly|monthly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly||
new_0222_0040|MRVI|5|136.75|136.75|136.75|136.75|136.75|136.75|136.75|136.75||136.75|136.75||1.45367412141|90.5|1.44755244755|90.5|1.45367412141|1.45683453237|1.44755244755||91.1666666667|1.45367412141||15.25|136.75|136.75|136.75|90.5|90.5|31|31|90.5||91.1666666667|92|91.1666666667|91.1666666667|28.7777777778||136.75|91|91.1666666667|91.1666666667||91|90.5|91|91||91.1666666667|91.1666666667|91.1666666667|91.1666666667|91.1666666667|1.45367412141|1.45367412141|1.45367412141|1.44014084507|1.44262295082|15.25|1.44755244755|1.44755244755|1.44755244755|1.44755244755|91.3636363636|91.3636363636|91|91|91|91|13.5806451613|15.8846153846|15.5925925926|9.56818181818|15.5925925926|16.1923076923|17.9565217391|91.1666666667|91.1666666667|91.1666666667|183|183||183||
new_0222_0040|MRVI|6|4|4|4|4|4|4|4|4||4|4||313|2|286|2|313|278|286||6|313||28|4|4|4|2|2|1|2|2||6|1|6|6|9||4|3|6|6||3|2|3|3||6|6|6|6|6|313|313|313|284|61|28|286|286|286|286|11|11|3|3|3|3|31|26|27|44|27|26|23|6|6|6|2|2||2||
new_0222_0040|MRVI|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly||
new_0222_0040|MRVI|201912|60.552|24.7|14.202|94.311|422.128|433.169|29.562|403.607||141.396|-42.381||||||||||2.3854||||18.03|12.508|183.91|||||||257.6206||-0.0365|15.784|||257.6206||1.4454|-0.0362|||||||35.96|18.13|-6.41|-9.407|-7.719||||||||||||||||||||||||0.979|6.635|7.719|8.516|68.887||14.629||
new_0222_0040|MRVI|202003||||||||||||||||||||||||||||||||||257.6206||0.0908|16.126||||||0.0268|||||||50.981|35.684|27.514|23.389|-7.382|||||||||||0.0704|50.9807||||||||||||3.744|6.766|7.382||||||
new_0222_0040|MRVI|202006||||||||||||||||||||||||||||||||||257.6206||0.0008|15.988||||||0.0008|||||||46.905|25.708|0.677|0.207|-7.463|||||||||||0.0192|46.902||||||||||||1.6|6.475|7.463||||||
new_0222_0040|MRVI|202009|145.553|36.314|26.586|96.089|407.096|702.118|280.451|421.667||-52.574|-52.41||34.1328||||32.7102|130.3404|||-6.6897|||0.65|73.301|11.033|||||||26.939|257.6206|390|0.1609|20.51|257.6206||257.6206|0.5608|0.3909|0.1609||2.566||55.639|221.705||87.859|68.099|38.664|41.45|-7.089|28.15|28.15|7567.4099|||628183|||||0.1699|87.8607||||||||||||1.868|6.671|7.089||||||
new_0222_0040|MRVI|202012|331.598|236.184|33.301|101.305|401.931|1115.945|130.778|985.167||88.511|0.854||26.7194|97.1054|59.8752|5.9739|25.4358|73.3356|81.6425||6.0401|||3.1998|51.018|11.067|2.576|15.9491|6|||132.2461||257.6206|58|0.13|41.621|257.6206||257.6206||2.1961|0.1587||3.5253|132.2461|78.172|284.098||98.353|74.958|14.841|13.126|-8.806|28.05|28.05|7590.9228|1376926.3||3092466|20.2445|21.4196|9.4581|9.149|0.0925|89.5892|39.2193|9.7822|0.1288|98.353|275.2546|429.5537|32.7778|1.3|9|0.3322|0.6005|2.092|5.925|8.806|0.818|63.331||25.789|34.84|32.52
new_0222_0040|MRVI|202103|425.543|247.675|47.129|105.133|396.891|1142.012|165.252|976.76||112.611|24.101||25.0825|122.5767|61.4656|7.0757|20.3173|67.0304|81.5338||4.7384|||7.4879|121.821|11.104|2.576|13.5168|6|||107.6484||96.673||0.24|23.237|257.6206||257.6206||2.236|0.1884||9.0119|107.6484|78.03|381.328||148.211|117.843|89.561|23.247|-8.77|35.64|35.64|9564.6612|1510585.9||7236836|25.7225|27.2155|12.0173|11.6246|0.2136|139.4606|21.7115|6.2744|0.26|148.211|608.1825|612.6701|48.7778|1.3|9|0.9092|0.8942|2.164|6.894|8.77|||||38.91|37.54
new_0222_0040|MRVI|202106|644.491|374.71|47.781|104.751|277.882|1268.106|164.773|1103.333||193.921|73.176||20.0095|87.0717|35.7946|6.9004|13.682|42.981|55.4459||2.7464|||4.2642|83.534|16.829|2.576|19.5411|8|||131.1296||112.2804||0.44|24.085|257.6595||257.6595||2.7811|0.44||8.693|131.1296|126.898|552.198||217.775|180.262|145.73|49.075|-8.512|41.73|41.73|11049.2239|1276398.1667||4876156|30.1178|31.8659|14.0729|13.613|0.3208|195.4946|37.1657|11.397|0.44|217.775|707.7552|732.7247|49.3333|1.3|9|1.1665|1.1339|1.932|7.338|8.512|||||43.97|59.18
new_0222_0040|MRVI|202109|||||||||||||23.4391||41.9297||16.0918|50.5513|65.2118|||||2.9119|||||||0.3202||||||||||||||||||||||||49.08|49.08|12943.0213|2069418.8|63.1972|3826790|35.4225|37.4785|16.5516|16.0107|0.3518|201.4994|25.0888|1.643|0.44|204.81|764.725|797.5406|59.375|1.2222|8|1.3867|1.324||||||||42.29|45.94
new_0222_0040|MRVI|202112|||||||||||||20.0889||35.9365||13.7377|43.1149|55.6718|||||2.9583||||||9|0.1073||||||||||||||||||||||||41.9|41.9|11093.026|1256969.1|49.3761|3888966|27.3676|34.0739|12.5611|14.3965|0.3866|208.0894|||||779.1422|761.5249|57.125|1.2222|8|1.5167|1.2547||||||||28.92|32.75
new_0222_0040|MRVI|202203|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||0.3752|210.5322||||||||||||||||||||
new_0222_0040|MRVI|202206|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||0.3802|214.2888||||||||||||||||||||
new_0222_0040|MRVI|202209|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||0.3815|217.8049||||||||||||||||||||
new_0222_0040|MRVI|202212|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||0.3676|219.9037||||||||||||||||||||